+ Site Statistics
References:
54,258,434
Abstracts:
29,560,870
PMIDs:
28,072,757
+ Search Articles
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ PDF Full Text
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Translate
+ Recently Requested

Statins and the colorectum: hope for chemoprevention?



Statins and the colorectum: hope for chemoprevention?



Cancer Prevention Research 3(5): 573-575



This perspective on Bertagnolli et al. (beginning on p. 588 in this issue of the journal) and Lipkin et al. (beginning on p. 597) considers the likelihood that statins have chemopreventive efficacy in the large bowel. An observational analysis within a clinical trial of celecoxib found no benefit of statin use on the risk of colorectal adenomas (and some suggestions of an adverse effect). On the other hand, variation in the 3-hydroxy-3-methylglutaryl coenzyme A reductase gene modified the association of statins with risk of colorectal cancer. The perspective discusses the implications of these data and how they fit into the context of previous investigations.

(PDF emailed within 0-6 h: $19.90)

Accession: 055911870

Download citation: RISBibTeXText

PMID: 20403999

DOI: 10.1158/1940-6207.CAPR-10-0050


Related references

Bioactivity of Oral Linaclotide in Human Colorectum for Cancer Chemoprevention. Cancer Prevention Research 10(6): 345-354, 2017

Animal Models of Carcinogenesis in Inflamed Colorectum Potential Use in Chemoprevention Study. Current Drug Targets 13(14): 1689-1697, 2012

A role for statins in chemoprevention?. Lancet. Oncology 5(7): 391-391, 2004

Melanoma chemoprevention: a role for statins or fibrates?. American Journal of Therapeutics 10(3): 203-210, 2003

Chemoprevention for hepatocellular carcinoma: the role of statins. Hepatobiliary Surgery and Nutrition 2(1): 1-3, 2014

Consideration of statins for chemoprevention of cutaneous melanoma. Journal of Drugs in Dermatology 4(1): 125-128, 2005

Rationale for statins in the chemoprevention of prostate cancer. Current Urology Reports 9(3): 189-196, 2008

Statins and metformin for chemoprevention of hepatocellular carcinoma. Clinical Liver Disease 8(2): 48-52, 2019

The potential for statins in the chemoprevention and management of hepatocellular carcinoma. 2012

Statins and Breast Cancer: Future Directions in Chemoprevention. Current Breast Cancer Reports 5(3): 161-169, 2013

The potential of statins for individualized colorectal cancer chemoprevention. Current Drug Targets 12(13): 1903-1908, 2012

Statins: emerging role in chemoprevention for hepatocellular carcinoma?. Hepatobiliary Surgery and Nutrition 2(2): 117-120, 2014

Potential for statins in the chemoprevention and management of hepatocellular carcinoma. Journal of Gastroenterology and Hepatology 27(11): 1654-1664, 2013

Statins emerging role in chemoprevention for hepatocellular carcinoma?. 2013

Statins for chemoprevention of hepatocellular carcinoma: assessing the evidence. Expert Review of Gastroenterology and Hepatology 7(6): 493-495, 2014